Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
18,211 total articles
Mereo BioPharma reported a net loss reduction in Q2 2026 compared to Q2 2025, extended cash runway into late 2027, and entered a key option and license agreement with Sentynl Therapeutics for alvelestat, targeting alpha-1 antitrypsin deficiency-associated lung disease. The company is engaging with regulators on setrusumab for osteogenesis imperfect…
Catheter Precision, Inc.'s subsidiary Flyte announced a strategic partnership with The Nucleus Network to support their inaugural flagship founder and investor event. This collaboration highlights Flyte's commitment to embedding itself within the entrepreneurial and venture capital ecosystem through networking and relationship-building. Flyte aims …
Astrotech Corporation announced that its subsidiary, Lunar Power and Light Corporation (LP&L), intends to develop a commercial lunar electric utility to provide continuous power on the lunar surface using solar towers and battery storage. The initiative aims to serve various lunar operations including construction, data centers, mining, and robotic…
Howard Hughes Holdings Inc. announced that its 2026 Annual Shareholder Meeting will be held on September 30, 2026, in New York City. The meeting will feature presentations from key executives, including updates on company strategy, business priorities, and long-term growth initiatives. Shareholders will have the opportunity to engage in a Q&A sessi…
Clearmind Medicine announced successful results from a permeation study of its proprietary intranasal MEAI formulation, showing enhanced nasal residence time without compromising drug delivery. The formulation maintains effective permeation rates comparable to conventional solutions while significantly extending nasal retention, which supports its …
Teva Pharmaceutical Industries Ltd. announced that Moody's Ratings has upgraded its corporate credit rating to Baa3 from Ba1, achieving investment-grade status with a stable outlook. This upgrade reflects Teva's successful execution of its Pivot to Growth strategy, including revenue diversification, improved operating margins, debt reduction, and a…
TON Strategy Company reported robust second quarter 2026 financial results driven by increased Gram staking revenue, rising from $3.0 million to $15.0 million quarter-over-quarter, largely due to the TON network's Catchain 2.0 upgrade. The company holds approximately 230.5 million Gram tokens, representing 4.4% of total supply and 35% of staked tok…
Theriva Biologics announced key clinical progress with the initiation of the VIRAGE2 Phase 2a trial evaluating more frequent dosing of its lead oncolytic adenovirus candidate, VCN-01, in metastatic pancreatic cancer. The company also discussed upcoming milestones, including a proposed Phase 2/3 trial for retinoblastoma and published positive Phase …
Nocera, Inc. (NASDAQ:NCRA) announced a joint venture with INERGX Energy Optimisation Ltd to form Nocera-INERGX Energy Ventures, Inc., aiming to acquire and develop companies across the energy supply chain related to Battery Energy Storage Systems, AI-enabled energy management, and infrastructure projects. The JV intends to enhance control over supp…
Kalaris Therapeutics announced its second quarter 2026 financial results, highlighting progress in its Phase 1b/2 clinical trial of TH103 for neovascular Age-related Macular Degeneration. The company successfully manufactured new clinical material batches, expanded leadership, and maintains a strong cash position to fund operations through late 202…
LB Pharmaceuticals reported Q2 2026 financial results and provided updates on its lead drug candidate LB-102, an investigational benzamide antipsychotic for neuropsychiatric disorders including schizophrenia and mood disorders. The company announced accelerated topline data from its pivotal Phase 3 schizophrenia trial expected in H1 2027, ahead of …
Baiya International Group Inc. announced an additional $2 million strategic investment in Binance Coin (BNB), bringing its total investments to $3 million. This move advances the company's long-term digital asset strategy, diversifies its portfolio, and optimizes capital allocation through its Binance Plan and quantitative trading framework, which …
Fort Technology Inc. announced entering into an agreement to acquire 50.1% of Logia USA, a company specializing in automated fuel integrity solutions tailored for data centers and mission-critical facilities. The acquisition includes a licensing agreement with Logia Israel for exclusive US rights to develop, manufacture, and commercialize these sys…
Callan JMB Inc., Bia Power Systems LLC, and Alabama State University announced a joint venture to establish an advanced electrical equipment manufacturing and assembly facility in Brewton, Alabama. This $60 million investment aims to expand domestic production of transformers and power-distribution equipment to meet growing demand in utilities, dat…
Big Sky Industrial Inc. reported Q2 2026 financial results highlighting ongoing construction of its Phase 1 helium processing facility at the Big Sky Carbon Hub with targeted first revenue in Q1 2027. The company executed a five-year, 100% take-or-pay helium offtake agreement at a fixed price of $285/Mcf, amended its senior secured credit facility …
Circle8 Group, Inc. has been ranked as the number one Broker/MSP provider in Dutch public-sector contract awards for 2025, capturing approximately €2.07 billion (~US$2.39 billion) across six framework agreements. This leading position underscores its strong presence in the public-sector workforce market in the Netherlands and provides significant o…
Protara Therapeutics announced its second quarter 2026 financial results and provided updates on its clinical pipeline, including enrollment progress in its ADVANCED-2 and STARBORN-1 trials, and the redesign of the ADVANCED-3 trial to broaden data collection in non-muscle invasive bladder cancer. The company anticipates submitting a Biologics Licen…
YD Bio Limited announced the launch of two physician-partnered chrono-nutrition nutraceutical formulations in Taiwan, developed collaboratively with the Taiwan Chronic Disease Healthcare Association and the Future Health Institute. This initiative marks the company's first step in building a repeatable physician-partnership ecosystem aimed at meeti…
Abundia Global Impact Group, Inc. announced significant progress in its commercialization strategy during Q2 2026, including the acquisition and integration of RPD Technologies, expansion of its Cedar Port facility, and securing strategic partnerships such as with Topsoe and Burns & McDonnell. The company increased revenue to $2 million for the qua…
Mereo BioPharma has partnered with Sentynl Therapeutics to grant Sentynl exclusive US commercialization and global manufacturing rights for alvelestat, an investigational oral treatment for Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD). The agreement includes upfront payments, milestone potential up to $435 million, and royalties…
CN announced a record movement of over 33.8 million metric tonnes of grain from Western Canada during the 2025-26 crop year, surpassing the previous year's record. This growth was driven by strong customer demand and operational efficiency. CN also released its 2026-27 Grain Plan aimed at further supporting the grain supply chain in the upcoming ha…
Adamas Trust, Inc., a U.S.-based REIT listed on Nasdaq, announced an 11.1% increase in its quarterly common stock dividend from $0.27 to $0.30 per share for the quarter ending September 30, 2026. The dividend payment is scheduled for October 28, 2026. CEO Jason Serrano highlighted the dividend increase as a reflection of the company’s strong earnin…
AXIL Brands, Inc., a consumer products company specializing in hearing protection and hair and skin care products, plans to release its fiscal Q4 and full year 2026 earnings on August 18, followed by a conference call for a corporate update and Q&A with investors.
IMUNON, Inc. announced its second quarter 2026 financial results and provided an update on the development of its lead DNA-based immunotherapy candidate, IMNN-001, for newly diagnosed advanced ovarian cancer. The company highlighted accelerated enrollment in the pivotal Phase 3 OVATION 3 trial, promising Phase 2 data showing significant overall sur…
Village Farms International announces the introduction of easy-pour pouches for its Super Toast brand's milled cannabis flower, marking the first use of this packaging format in Canada. The innovation features a convenient spout, color-coded caps, and a window to view product freshness. Super Toast has become a leading national brand in Canada, wit…
